☆ 4.4 Article

Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study

OPHTHALMOLOGY AND THERAPY (2023)

Related references

Note: Only part of the references are listed.

Article Ophthalmology

The effect of atropine 0.01% eyedrops on relative peripheral refraction in myopic children

Jiaxin Tian et al.

Summary: This study evaluated the effects of atropine 0.01% eyedrops on relative peripheral refraction (RPR) and found that it can alleviate relative hyperopia in the temporal retina and the hyperopic shift before cycloplegia in myopic children, suggesting a role in myopia control.

EYE (2023)

Add to Collection

Article Ophthalmology

Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout Phase 3 Report

Jason C. Yam et al.

Summary: The study aimed to compare the efficacy of different concentrations of atropine treatment in the third year, evaluate the efficacy of continued treatment over 3 years, and investigate the rebound phenomenon after cessation of treatment. The results showed that continued treatment achieved better outcomes in terms of myopia progression and axial elongation compared to the washout regimen across all concentrations. The optimal concentration for 3-year treatment in Chinese children was 0.05% atropine.

OPHTHALMOLOGY (2022)

Add to Collection

Article Ophthalmology

Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children A Network Meta-Analysis

Ahnul Ha et al.

Summary: This study compares the efficacy and safety of different concentrations of atropine for myopia control through network meta-analysis. The results show that the 1%, 0.5%, and 0.05% concentrations of atropine are ranked as the most beneficial for myopia control in terms of yearly changes in refraction and axial length. The 0.05% concentration of atropine is ranked as the most beneficial for overall myopia progression. The risk of adverse effects tends to increase with higher atropine concentrations.

OPHTHALMOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Complex Interplay Between COVID-19 Lockdown and Myopic Progression

Tao Cai et al.

Summary: During the COVID-19 pandemic, the decline in outdoor activities and increase in exposure time to digital screens accelerated myopia progression by approximately one-third. Risk factors for myopia progression included heredity, prolonged indoor work, and electronic device usage, while protective factors included age, rest time after continuous eye usage, sleep duration, and distance from the eyes to computer screens.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Ophthalmology

Age Effect on Treatment Responses to 0.05%, 0.025%, and 0.01% Atropine Low-Concentration Atropine for Myopia Progression Study

Fen Fen Li et al.

Summary: Younger age is associated with poor treatment response to low-concentration atropine at 0.05%, 0.025%, and 0.01%. Among concentrations studied, younger children required the highest 0.05% concentration to achieve similar reduction in myopic progression as older children receiving lower concentrations.

OPHTHALMOLOGY (2021)

Add to Collection

Article Ophthalmology

Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children

Qi Zhao et al.

Summary: The study found that 0.01% atropine can effectively control the progression of myopia and axial elongation in children, regardless of whether combined with spectacles or OK lenses. Atropine has no significant effect on Schirmer's test and tear film break-up time results, but researchers also observed a tendency for these results to decrease after treatment with 0.01% atropine.

INTERNATIONAL OPHTHALMOLOGY (2021)

Add to Collection

Article Ophthalmology

Peripheral Refraction in Myopic Children with and without Atropine Usage

Han-Yin Sun et al.

JOURNAL OF OPHTHALMOLOGY (2020)

Add to Collection

Article Ophthalmology

One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial

Qi Tan et al.

OPHTHALMIC AND PHYSIOLOGICAL OPTICS (2020)

Add to Collection

Article Multidisciplinary Sciences

Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial

Nozomi Kinoshita et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Ophthalmology

Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-A preliminary retrospective study

Zhi Chen et al.

CONTACT LENS & ANTERIOR EYE (2019)

Add to Collection

Article Ophthalmology

Axial Growth and Lens Power Loss at Myopia Onset in Singaporean Children

Jos Rozema et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)

Add to Collection

Article Ophthalmology

Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results

Nozomi Kinoshita et al.

JAPANESE JOURNAL OF OPHTHALMOLOGY (2018)

Add to Collection

Article Ophthalmology

The epidemics of myopia: Aetiology and prevention

Ian G. Morgan et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2018)

Add to Collection

Article Ophthalmology

Efficacy, Safety and Acceptability of Orthokeratology on Slowing Axial Elongation in Myopic Children by Meta-Analysis

Shi-Ming Li et al.

CURRENT EYE RESEARCH (2016)

Add to Collection

Article Ophthalmology

Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2 Myopia Control with Atropine 0.01% Eyedrops

Audrey Chia et al.

OPHTHALMOLOGY (2016)

Add to Collection

Article Ophthalmology

Efficacy Comparison of 16 Interventions for Myopia Control in Children A Network Meta-analysis

Jinhai Huang et al.

OPHTHALMOLOGY (2016)

Add to Collection

Article Ophthalmology

Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050

Brien A. Holden et al.

OPHTHALMOLOGY (2016)

Add to Collection

Article Ophthalmology

Influence of Ocular Wavefront Aberrations on Axial Length Elongation in Myopic Children Treated with Overnight Orthokeratology

Takahiro Hiraoka et al.

OPHTHALMOLOGY (2015)

Add to Collection

Article Ophthalmology

The control effect of orthokeratology on axial length elongation in Chinese children with myopia

Meng-Jun Zhu et al.

BMC OPHTHALMOLOGY (2014)

Add to Collection

Article Ophthalmology

How does atropine exert its anti-myopia effects?

N. A. McBrien et al.

OPHTHALMIC AND PHYSIOLOGICAL OPTICS (2013)

Add to Collection

Article Ophthalmology

Factors Preventing Myopia Progression with Orthokeratology Correction

Jacinto Santodomingo-Rubido et al.

OPTOMETRY AND VISION SCIENCE (2013)

Add to Collection

Article Ophthalmology

Myopia Control Using Toric Orthokeratology (TO-SEE Study)

Connie Chen et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)

Add to Collection

Article Medicine, General & Internal

Ophthalmology 2 Myopia

Ian G. Morgan et al.

LANCET (2012)

Add to Collection

Article Ophthalmology

Impact of Pupil Diameter on Axial Growth in Orthokeratology

Zhi Chen et al.

OPTOMETRY AND VISION SCIENCE (2012)

Add to Collection

Article Ophthalmology

Retardation of Myopia in Orthokeratology (ROMIO) Study: A 2-Year Randomized Clinical Trial

Pauline Cho et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)

Add to Collection

Article Ophthalmology

Long-Term Effect of Overnight Orthokeratology on Axial Length Elongation in Childhood Myopia: A 5-Year Follow-Up Study

Takahiro Hiraoka et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)

Add to Collection

Article Ophthalmology

Influence of Overnight Orthokeratology on Axial Elongation in Childhood Myopia

Tetsuhiko Kakita et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)

Add to Collection

Article Ophthalmology

Effect of Orthokeratology on Peripheral Aberrations of the Eye

Ankit Mathur et al.

OPTOMETRY AND VISION SCIENCE (2009)

Add to Collection

Review Ophthalmology

Myopia and associated pathological complications

SM Saw et al.

OPHTHALMIC AND PHYSIOLOGICAL OPTICS (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.